Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats
about
What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.Monoamine reuptake inhibitors in Parkinson's disease.Ranitidine reduced levodopa-induced dyskinesia by remodeling neurochemical changes in hemiparkinsonian model of rats.Multisite intracerebral microdialysis to study the mechanism of L-DOPA induced dopamine and serotonin release in the parkinsonian brainEffects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian ratsCatecholamine/Serotonin interactions: systems thinking for brain function and diseaseThe serotonergic system in motor and non-motor manifestations of Parkinson's disease.Interaction between the 5-HT system and the basal ganglia: functional implication and therapeutic perspective in Parkinson's disease.Serotonin System Implication in l-DOPA-Induced Dyskinesia: From Animal Models to Clinical Investigations.D-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats.The acute and long-term L-DOPA effects are independent from changes in the activity of dorsal raphe serotonergic neurons in 6-OHDA lesioned rats.Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease.
P2860
Q28078271-CF2121CA-E5BA-45DD-BE72-AD1D915C7774Q34795714-27F8E9E9-8429-454E-922C-44ABF4087607Q35165280-1E4AE8E8-1684-45BC-9770-C4AF287BC17DQ35683816-8E1AC115-B7DD-457A-85FE-9FB2E0A81BE7Q36851713-20FAFD56-21D2-4BA8-8015-F5679204CA32Q37397245-7DB6362F-00E6-48E5-A93E-13F169262BFAQ37518766-6200EFF2-ACAA-43A6-AAA2-6E51143517BFQ38118061-D85516DE-6506-4B40-AA55-53AC1383716EQ38199670-5C1BD973-7F3A-47AE-B74A-F942626A6D38Q38218100-DBDBEDF6-543A-4B52-B9F6-696CFBAE9BE8Q38699002-C10D8D1A-5E2E-4678-8C07-55C39003D676Q41963193-FEA36889-86E9-4B30-9E02-4D28E83EEFA2Q48300577-F6CE419F-808D-4195-8E00-7C0151771D3BQ51047922-DE7CAABB-9E16-44F7-927A-DDFB3CBE473C
P2860
Serotonin transporter inhibition attenuates l-DOPA-induced dyskinesia without compromising l-DOPA efficacy in hemi-parkinsonian rats
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Serotonin transporter inhibiti ...... cacy in hemi-parkinsonian rats
@ast
Serotonin transporter inhibiti ...... cacy in hemi-parkinsonian rats
@en
type
label
Serotonin transporter inhibiti ...... cacy in hemi-parkinsonian rats
@ast
Serotonin transporter inhibiti ...... cacy in hemi-parkinsonian rats
@en
prefLabel
Serotonin transporter inhibiti ...... cacy in hemi-parkinsonian rats
@ast
Serotonin transporter inhibiti ...... cacy in hemi-parkinsonian rats
@en
P2093
P2860
P1476
Serotonin transporter inhibiti ...... cacy in hemi-parkinsonian rats
@en
P2093
Adam A Goldenberg
Christopher Bishop
Jessica A George
Karen L Eskow Jaunarajs
Mohamed Mohamed
Sando O Dickinson
Satie Eissa
William Buchta
P2860
P304
P356
10.1111/J.1460-9568.2012.08202.X
P407
P577
2012-07-05T00:00:00Z